Dr. Berger is director of the Institute of Oncology at the SMC.
He is also secretary of the Society of Clinical Oncology and Radiotherapy. He was a postdoctoral fellow at the Dana Farber Cancer Institute at Harvard Medical School. In 2006, he established the an Oncology Clinical Research Center, SMC, which is a large all-phase oncology clinical trials center, currently conducting over 200 advanced clinical trials backed by the biggest pharmaceutical conglomerates and top scientists in the world.
Dr Berger led his institute to become one of the most active partners in the world wide initiative networking (WIN) Consortium and he is the PI of the WINTHER-1 trial for personalized cancer medicine.
Additionally, Dr. Berger has founded the “360 Oncology Care Program” to improve the support for cancer patients and to change the face of oncology care.